Protalix BioTherapeutics, Inc. (PLX)

Last Closing Price: 1.75 (2025-11-21)

Expense Ratio (Quarterly)

Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned

Protalix BioTherapeutics, Inc. (PLX) Expense Ratio data is not available.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
$17.85M
$2.35M
$8.32M
$9.53M
$15.72M
$2.13M
$0.11M
$2.24M
$2.24M
$2.35M
$2.35M
$2.35M
$2.35M
$2.13M
$2.50M
79.28M
80.81M
$0.03
$0.03
Balance Sheet Financials
$66.50M
$4.72M
$15.76M
$82.26M
$21.95M
--
$7.41M
$29.36M
$52.91M
$52.91M
$52.91M
80.34M
Cash Flow Statement Financials
$-14.02M
$-1.25M
$9.18M
$19.76M
$13.65M
$-6.11M
$1.56M
--
--
Fundamental Metrics & Ratios
3.03
--
--
--
--
53.37%
11.94%
11.94%
--
12.54%
13.19%
$-15.26M
--
Expense Ratio
--
--
0.22
0.39
1.24
72.73
4.45%
4.45%
2.86%
4.45%
$0.66
$-0.19
$-0.17